US Stocks
/
Aardvark Therapeutics, Inc. Share Price

Aardvark Therapeutics, Inc. Share Price

NASDAQ: AARD | Micro Cap
$1.52
+$0.21 (16.41%) Last updated on 29 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Aardvark Therapeutics, Inc. Stock Performance

Open
$1.23
Prev. Close
$1.31
Circuit Range
N/A
Day Range
$1.18 - $1.58
Year Range
$0.94 - $16.41
Volume
37,362
Average Traded
$1.47

Aardvark Therapeutics, Inc. Share Price Today

As of 29 October 2026, Aardvark Therapeutics, Inc.'s share price is $1.52. The stock opened at $1.23, compared to its previous close of $1.31. During today's trading session, Aardvark Therapeutics, Inc.'s share price traded between $1.18 and $1.58, with an average price of $1.38. Over the past 52 weeks, the stock has recorded a high of $16.41 and a low of $0.94. In terms of performance, Aardvark Therapeutics, Inc.'s share price has declined by 71.84% over the last six months and is down 85.63% on a year-on-year basis.

Aardvark Therapeutics, Inc. Share Price Chart

$1.18$1.58
L
Show Current Price
H

Aardvark Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$29.93M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-3.19
Revenue (TTM)
$0.00
Return On Equity (TTM)
-93.44%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
11.83%

Aardvark Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$16.32-$17.60-$21.59-$14.39
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-7.84%-22.67%33.35%

Aardvark Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2025
Revenue$0.00
Net Profit-$57.59
Net Profit MarginN/A
Income ChangeN/A

About Aardvark Therapeutics, Inc.

Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.

Aardvark Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$5.23
$1.56
-70.48%
Sep 2026
$6.22
$5.29
-20.53%
Aug 2026
$6.74
$6.65
+2.62%
Jul 2026
$5.76
$6.48
+12.60%
Jun 2026
$3.98
$5.75
+40.02%
May 2026
$5.17
$4.11
-24.10%
Apr 2026
$3.87
$5.42
+44.40%
Mar 2026
$5.72
$3.75
-70.20%
Feb 2026
$12.80
$12.59
-2.97%
Jan 2026
$12.60
$12.97
-0.92%
Dec 2025
$9.95
$13.09
+31.43%
Nov 2025
$10.41
$9.96
-6.13%

AARD Share Price FAQs

What is Aardvark Therapeutics, Inc. share price today?

chevron-up
Aardvark Therapeutics, Inc. share price today is $1.52 as on October 29, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Aardvark Therapeutics, Inc. stock?

chevron-up
The 52 week high of Aardvark Therapeutics, Inc. stock is $16.41, while the 52 week low is $0.94 as of 29 Oct '26.

What is AARD's market capitalisation today?

chevron-up
AARD market capitalisation is $29.93M as of October 29, 2026, at 4:54 am IST.

What is AARD's net income for the last quarter?

chevron-up
AARD's net income for the last quarter is -14.39B USD.

What is the 5 year returns of AARD?

chevron-up
The 5 year returns of AARD is -87.88% as on 29 Oct '26.

What is the high & low stock price of AARD today?

chevron-up
AARD stock price hit a high of $1.58 and low of $1.18 as of 29 Oct '26.

Can I buy AARD shares in India?

chevron-up
Yes. You can buy AARD in India by opening an international trading account.